Genetic Variants Associated With Glycine Metabolism and Their Role in Insulin Sensitivity and Type 2 Diabetes

Circulating metabolites associated with insulin sensitivity may represent useful biomarkers, but their causal role in insulin sensitivity and diabetes is less certain. We previously identified novel metabolites correlated with insulin sensitivity measured by the hyperinsulinemic-euglycemic clamp. The top-ranking metabolites were in the glutathione and glycine biosynthesis pathways. We aimed to identify common genetic variants associated with metabolites in these pathways and test their role in insulin sensitivity and type 2 diabetes. With 1,004 nondiabetic individuals from the RISC study, we performed a genome-wide association study (GWAS) of 14 insulin sensitivity–related metabolites and one metabolite ratio. We replicated our results in the Botnia study (n = 342). We assessed the association of these variants with diabetes-related traits in GWAS meta-analyses (GENESIS [including RISC, EUGENE2, and Stanford], MAGIC, and DIAGRAM). We identified four associations with three metabolites—glycine (rs715 at CPS1), serine (rs478093 at PHGDH), and betaine (rs499368 at SLC6A12; rs17823642 at BHMT)—and one association signal with glycine-to-serine ratio (rs1107366 at ALDH1L1). There was no robust evidence for association between these variants and insulin resistance or diabetes. Genetic variants associated with genes in the glycine biosynthesis pathways do not provide consistent evidence for a role of glycine in diabetes-related traits.

[1]  SoJung Lee,et al.  Metabolomic profiling of amino acids and β-cell function relative to insulin sensitivity in youth. , 2012, The Journal of clinical endocrinology and metabolism.

[2]  Ayellet V. Segrè,et al.  Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis , 2010, Nature Genetics.

[3]  M. Walker,et al.  The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and Objectives , 2004, Diabetologia.

[4]  Yun Li,et al.  METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..

[5]  J. Hausman.  Specification tests in econometrics , 1978 .

[6]  H. Blom,et al.  Betaine-homocysteine methyltransferase (BHMT): genomic sequencing and relevance to hyperhomocysteinemia and vascular disease in humans. , 2000, Molecular Genetics and Metabolism.

[7]  J. Gregory,et al.  Glycine turnover and decarboxylation rate quantified in healthy men and women using primed, constant infusions of [1,2-(13)C2]glycine and [(2)H3]leucine. , 2007, The Journal of nutrition.

[8]  A. Balasubramanyam,et al.  Glutathione Synthesis Is Diminished in Patients With Uncontrolled Diabetes and Restored by Dietary Supplementation With Cysteine and Glycine , 2010, Diabetes Care.

[9]  Christian Gieger,et al.  A genome-wide perspective of genetic variation in human metabolism , 2010, Nature Genetics.

[10]  T. Hansen,et al.  The common SLC30A8 Arg325Trp variant is associated with reduced first-phase insulin release in 846 non-diabetic offspring of type 2 diabetes patients—the EUGENE2 study , 2008, Diabetologia.

[11]  Luigi Ferrucci,et al.  Genome-Wide Association Study of Plasma Polyunsaturated Fatty Acids in the InCHIANTI Study , 2009, PLoS genetics.

[12]  R. DeFronzo,et al.  Impairment of Insulin-mediated Glucose Metabolism by Hyperosmolality in Man , 1983, Diabetes.

[13]  Corey D. DeHaven,et al.  Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. , 2009, Analytical chemistry.

[14]  G. Paolisso,et al.  Glutathione Infusion Potentiates Glucose-Induced Insulin Secretion in Aged Patients With Impaired Glucose Tolerance , 1992, Diabetes Care.

[15]  Juan P Casas,et al.  Estimation of bias in nongenetic observational studies using "mendelian triangulation". , 2006, Annals of epidemiology.

[16]  J. House,et al.  Plasma homocysteine and glycine are sensitive indices of folate status in a rodent model of folate depletion and repletion. , 2003, Journal of agricultural and food chemistry.

[17]  George Davey Smith,et al.  Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology , 2008, Statistics in medicine.

[18]  E. Cerasi,et al.  Splanchnic and peripheral glucose and amino acid metabolism in diabetes mellitus. , 1972, The Journal of clinical investigation.

[19]  Yun Li,et al.  Genome-wide association study of homocysteine levels in Filipinos provides evidence for CPS1 in women and a stronger MTHFR effect in young adults. , 2010, Human molecular genetics.

[20]  L. Brennan,et al.  Amino acid metabolism, insulin secretion and diabetes. , 2007, Biochemical Society transactions.

[21]  Abraham Nyska,et al.  Discovery of Metabolomics Biomarkers for Early Detection of Nephrotoxicity , 2009, Toxicologic pathology.

[22]  G. Abecasis,et al.  MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes , 2010, Genetic epidemiology.

[23]  D. Lawlor,et al.  Re: Estimation of bias in nongenetic observational studies using "Mendelian triangulation" by Bautista et al. , 2007, Annals of epidemiology.

[24]  SiddharthPrakash.  Human Metabolic Individuality in Biomedical and Pharmaceutical Research , 2011 .

[25]  Fabian J Theis,et al.  Discovery of Sexual Dimorphisms in Metabolic and Genetic Biomarkers , 2011, PLoS genetics.

[26]  Inês Barroso,et al.  Mendelian Randomization Study of B-Type Natriuretic Peptide and Type 2 Diabetes: Evidence of Causal Association from Population Studies , 2011, PLoS medicine.

[27]  Hans-Werner Mewes,et al.  Bioinformatics analysis of targeted metabolomics--uncovering old and new tales of diabetic mice under medication. , 2008, Endocrinology.

[28]  G. Abecasis,et al.  Genotype imputation. , 2009, Annual review of genomics and human genetics.

[29]  G. Shulman,et al.  Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study. , 1997, Diabetes.

[30]  C. Gieger,et al.  Human metabolic individuality in biomedical and pharmaceutical research , 2011, Nature.

[31]  Mark I. McCarthy,et al.  Mendelian Randomization Studies Do Not Support a Role for Raised Circulating Triglyceride Levels Influencing Type 2 Diabetes, Glucose Levels, or Insulin Resistance , 2011, Diabetes.

[32]  S. Craig,et al.  Betaine in human nutrition. , 2004, The American journal of clinical nutrition.

[33]  K. Kalari,et al.  Betaine-homocysteine methyltransferase: human liver genotype-phenotype correlation. , 2011, Molecular genetics and metabolism.

[34]  J. Limbeek,et al.  Long-term reduction of plasma homocysteine levels by super-flux dialyzers in hemodialysis patients. , 2001, Kidney international.

[35]  M. Jarvelin,et al.  Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes , 2009, Human molecular genetics.

[36]  Luke Hunter,et al.  Interpreting Metabolomic Profiles using Unbiased Pathway Models , 2010, PLoS Comput. Biol..

[37]  Ru Wei,et al.  Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity , 2008, Molecular systems biology.

[38]  W. Kraus,et al.  Exercise-Induced Changes in Metabolic Intermediates, Hormones, and Inflammatory Markers Associated With Improvements in Insulin Sensitivity , 2010, Diabetes Care.

[39]  Svati H Shah,et al.  A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. , 2009, Cell metabolism.

[40]  L. Groop,et al.  Metabolic Consequences of a Family History of NIDDM (The Botnia Study): Evidence for Sex-Specific Parental Effects , 1996, Diabetes.

[41]  William E. Kraus,et al.  Relationships Between Circulating Metabolic Intermediates and Insulin Action in Overweight to Obese, Inactive Men and Women , 2009, Diabetes Care.

[42]  Michael Milburn,et al.  A Novel Fasting Blood Test for Insulin Resistance and Prediabetes , 2013, Journal of diabetes science and technology.

[43]  T. Hansen,et al.  Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study , 2008, Diabetologia.

[44]  Oliver Fiehn,et al.  Plasma Metabolomic Profiles Reflective of Glucose Homeostasis in Non-Diabetic and Type 2 Diabetic Obese African-American Women , 2010, PloS one.

[45]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.

[46]  Y. Le Marchand-Brustel,et al.  Hyperosmotic Stress Inhibits Insulin Receptor Substrate-1 Function by Distinct Mechanisms in 3T3-L1 Adipocytes* , 2003, Journal of Biological Chemistry.

[47]  Christian Gieger,et al.  New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk , 2010, Nature Genetics.

[48]  M. Milburn,et al.  Analysis of the adult human plasma metabolome. , 2008, Pharmacogenomics.

[49]  A. Barabasi,et al.  Hierarchical Organization of Modularity in Metabolic Networks , 2002, Science.

[50]  M. E. Clark,et al.  Living with water stress: evolution of osmolyte systems. , 1982, Science.

[51]  A. Peters,et al.  Identification of Serum Metabolites Associated With Risk of Type 2 Diabetes Using a Targeted Metabolomic Approach , 2013, Diabetes.

[52]  Christian Gieger,et al.  Novel biomarkers for pre-diabetes identified by metabolomics , 2012, Molecular systems biology.

[53]  Andrea Natali,et al.  α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population , 2010, PloS one.

[54]  G. Reaven,et al.  Assessment of Insulin Resistance with the Insulin Suppression Test and the Euglycemic Clamp , 1981, Diabetes.

[55]  V. Mootha,et al.  Metabolite profiles and the risk of developing diabetes , 2011, Nature Medicine.

[56]  M. Summar.  Molecular genetic research into carbamoyl-phosphate synthase I: Molecular defects and linkage markers , 1998, Journal of Inherited Metabolic Disease.